adenovirus-based combination vaccine (PaxVax/University of California San Diego)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameadenovirus-based combination vaccine (PaxVax/University of California San Diego)
Drug Alias NameN/A
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHerpes Simplex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPaxvax Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPaxvax IncUniversity Of California San Diego
Active IndicationsN/A
Inactive IndicationsHerpes Simplex

Other Information

ATC CodeN/A
Related LinksN/A